Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Etrumadenant by Arcus Biosciences for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Etrumadenant is under clinical development by Arcus Biosciences and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Data Insights
Etrumadenant by Arcus Biosciences for Metastatic Colorectal Cancer: Likelihood of Approval
Etrumadenant is under clinical development by Arcus Biosciences and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...